_id
69109590ccc777a4e85d5afc
Ticker
ELAB
Name
Elevai Labs, Inc. Common Stock
Exchange
NASDAQ
Address
120 Newport Center Drive, Newport Beach, CA, United States, 92660
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://pmgcholdings.com
Description
PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of cutting-edge aesthetic medicines and therapeutic products. The company's lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. It is also involved in the medical scientific research and development activities, as well as operates investment firms. The company was formerly known as Elevai Labs, Inc. and changed its name to PMGC Holdings Inc. in December 2024. PMGC Holdings Inc. was incorporated in 2020 and is based in Newport Beach, California.
Last Close
1.49
Volume
661913
Current Price
6.9696
Change
2.0357142857143
Last Updated
2026-01-02T13:14:18.245Z
Image
data:image/webp;base64,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
Ipo Date
2023-11-21T00:00:00.000Z
Market Cap
1101284
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.999
Sentiment Sources
1
Current Quarter
2025-09-30
Revenue
285948
Cost Of Revenue
243202
Gross Profit
42746
Operating Expenses
2237473
Operating Income
-2194727
Interest Expense
196880
Pretax Income
-2616018
Net Income
-2594320
Eps
-4.909096413811896
Dividends Per Share
-
Shares Outstanding
744110
Income Tax Expense
-
EBITDA
-2383854
Operating Margin
-767.5266132303775
Total Other Income Expense Net
-421291
Cash
7700562
Short Term Investments
804070
Receivables
369432
Inventories
128469
Total Current Assets
9772631
Property Plant Equipment
1657188
Total Assets
14938018
Payables
553879
Short Term Debt
3423282
Long Term Debt
-
Total Liabilities
6447363
Equity
8490655
Bs_currency_symbol
USD
Depreciation
35284
Change In Working Capital
632885
Cash From Operations
-1490167
Capital Expenditures
95593
Cash From Investing
-2198033
Cash From Financing
5705971
Net Change In Cash
2017934
Cf_currency_symbol
USD
PE
0.0037
PB
0.433799094557487
ROE
-30.555004295899437
ROA
-17.36723037822019
FCF
-1585760
Fcf Percent
-5.545623679829899
Piotroski FScore
1
Health Score
30
Deep Value Investing Score
8
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
1.5
Growth Investing Score
0.5
Momentum Investing Score
3.5
Net Net Investing Score
7.5
Quality Investing Score
2
Value Investing Score
7
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
285948
Quarters > 0 > income Statement > cost Of Revenue
243202
Quarters > 0 > income Statement > gross Profit
42746
Quarters > 0 > income Statement > operating Expenses
2237473
Quarters > 0 > income Statement > operating Income
-2194727
Quarters > 0 > income Statement > interest Expense
196880
Quarters > 0 > income Statement > pretax Income
-2616018
Quarters > 0 > income Statement > net Income
-2594320
Quarters > 0 > income Statement > eps
-4.909096413811896
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
528472
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-2383854
Quarters > 0 > income Statement > operating Margin
-767.5266132303775
Quarters > 0 > income Statement > total Other Income Expense Net
-421291
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
7700562
Quarters > 0 > balance Sheet > short Term Investments
804070
Quarters > 0 > balance Sheet > receivables
369432
Quarters > 0 > balance Sheet > inventories
128469
Quarters > 0 > balance Sheet > total Current Assets
9772631
Quarters > 0 > balance Sheet > property Plant Equipment
1657188
Quarters > 0 > balance Sheet > total Assets
14938018
Quarters > 0 > balance Sheet > payables
553879
Quarters > 0 > balance Sheet > short Term Debt
3423282
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
6447363
Quarters > 0 > balance Sheet > equity
8490655
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-2616018
Quarters > 0 > cash Flow > depreciation
35284
Quarters > 0 > cash Flow > change In Working Capital
632885
Quarters > 0 > cash Flow > cash From Operations
-1490167
Quarters > 0 > cash Flow > capital Expenditures
95593
Quarters > 0 > cash Flow > cash From Investing
-2198033
Quarters > 0 > cash Flow > cash From Financing
5705971
Quarters > 0 > cash Flow > net Change In Cash
2017934
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-4.909096413811896
Quarters > 0 > ratios > PB
0.433799094557487
Quarters > 0 > ratios > ROE
-30.555004295899437
Quarters > 0 > ratios > ROA
-17.36723037822019
Quarters > 0 > ratios > FCF
-1585760
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-5.545623679829899
Quarters > 0 > health Score
30
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
20
Quarters > 1 > income Statement > gross Profit
-20
Quarters > 1 > income Statement > operating Expenses
1014381
Quarters > 1 > income Statement > operating Income
-1014401
Quarters > 1 > income Statement > interest Expense
2
Quarters > 1 > income Statement > pretax Income
-579490
Quarters > 1 > income Statement > net Income
-562355
Quarters > 1 > income Statement > eps
-1.5825427959555254
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
355349
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-579471
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
434911
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
5682628
Quarters > 1 > balance Sheet > short Term Investments
624838
Quarters > 1 > balance Sheet > receivables
204323
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
7302844
Quarters > 1 > balance Sheet > property Plant Equipment
0
Quarters > 1 > balance Sheet > total Assets
9375476
Quarters > 1 > balance Sheet > payables
271567
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
326301
Quarters > 1 > balance Sheet > equity
9049175
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-562355
Quarters > 1 > cash Flow > depreciation
21
Quarters > 1 > cash Flow > change In Working Capital
-405318
Quarters > 1 > cash Flow > cash From Operations
-1346298
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
196840
Quarters > 1 > cash Flow > cash From Financing
1467583
Quarters > 1 > cash Flow > net Change In Cash
318194
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-1.5825427959555254
Quarters > 1 > ratios > PB
0.27368687094679905
Quarters > 1 > ratios > ROE
-6.2144339124837344
Quarters > 1 > ratios > ROA
-5.998148787325571
Quarters > 1 > ratios > FCF
-1346298
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
41
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
152381
Quarters > 2 > income Statement > cost Of Revenue
15443
Quarters > 2 > income Statement > gross Profit
-15443
Quarters > 2 > income Statement > operating Expenses
1185895
Quarters > 2 > income Statement > operating Income
-1201338
Quarters > 2 > income Statement > interest Expense
10474
Quarters > 2 > income Statement > pretax Income
-1580811
Quarters > 2 > income Statement > net Income
-1568779
Quarters > 2 > income Statement > eps
-10.079989462389083
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
155633
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-1554893
Quarters > 2 > income Statement > operating Margin
-788.3778161319325
Quarters > 2 > income Statement > total Other Income Expense Net
-379473
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
5364434
Quarters > 2 > balance Sheet > short Term Investments
557375
Quarters > 2 > balance Sheet > receivables
52140
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
6816148
Quarters > 2 > balance Sheet > property Plant Equipment
0
Quarters > 2 > balance Sheet > total Assets
8888780
Quarters > 2 > balance Sheet > payables
384418
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
760268
Quarters > 2 > balance Sheet > equity
8128512
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-1608455
Quarters > 2 > cash Flow > depreciation
1601
Quarters > 2 > cash Flow > change In Working Capital
-142682
Quarters > 2 > cash Flow > cash From Operations
-1347416
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-215319
Quarters > 2 > cash Flow > cash From Financing
2943185
Quarters > 2 > cash Flow > net Change In Cash
1379981
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-10.079989462389083
Quarters > 2 > ratios > PB
0.1334438279478458
Quarters > 2 > ratios > ROE
-19.29970700664525
Quarters > 2 > ratios > ROA
-17.64897995000439
Quarters > 2 > ratios > FCF
-1347416
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-8.842414736745395
Quarters > 2 > health Score
34
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
-1747570
Quarters > 3 > income Statement > cost Of Revenue
201434
Quarters > 3 > income Statement > gross Profit
-1747570
Quarters > 3 > income Statement > operating Expenses
-2100101
Quarters > 3 > income Statement > operating Income
352531
Quarters > 3 > income Statement > interest Expense
32522
Quarters > 3 > income Statement > pretax Income
294284
Quarters > 3 > income Statement > net Income
-1934739
Quarters > 3 > income Statement > eps
-134.16122321614313
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
14421
Quarters > 3 > income Statement > income Tax Expense
-2
Quarters > 3 > income Statement > EBITDA
330041
Quarters > 3 > income Statement > operating Margin
-20.17263972258622
Quarters > 3 > income Statement > total Other Income Expense Net
-58247
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
3984453
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
5276
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
6051000
Quarters > 3 > balance Sheet > property Plant Equipment
1087
Quarters > 3 > balance Sheet > total Assets
8993165
Quarters > 3 > balance Sheet > payables
481000
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
2333601
Quarters > 3 > balance Sheet > equity
6659564
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-1934739
Quarters > 3 > cash Flow > depreciation
3235
Quarters > 3 > cash Flow > change In Working Capital
-142410
Quarters > 3 > cash Flow > cash From Operations
-2000545
Quarters > 3 > cash Flow > capital Expenditures
300000
Quarters > 3 > cash Flow > cash From Investing
-439084
Quarters > 3 > cash Flow > cash From Financing
-1
Quarters > 3 > cash Flow > net Change In Cash
-2441217
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-134.16122321614313
Quarters > 3 > ratios > PB
0.015092369650625775
Quarters > 3 > ratios > ROE
-29.052037040262697
Quarters > 3 > ratios > ROA
-21.513438261168343
Quarters > 3 > ratios > FCF
-2300545
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
1.3164250931293167
Quarters > 3 > health Score
51
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
2467298
Annuals > 0 > income Statement > cost Of Revenue
670197
Annuals > 0 > income Statement > gross Profit
1797101
Annuals > 0 > income Statement > operating Expenses
3663566
Annuals > 0 > income Statement > operating Income
-1866566
Annuals > 0 > income Statement > interest Expense
735197
Annuals > 0 > income Statement > pretax Income
-4016714
Annuals > 0 > income Statement > net Income
-6245737
Annuals > 0 > income Statement > eps
-274.68277772891196
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
22738
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-3198415
Annuals > 0 > income Statement > operating Margin
-75.65223171258599
Annuals > 0 > income Statement > total Other Income Expense Net
-2149714
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
3984453
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
5276
Annuals > 0 > balance Sheet > inventories
1044
Annuals > 0 > balance Sheet > total Current Assets
6051000
Annuals > 0 > balance Sheet > property Plant Equipment
1087
Annuals > 0 > balance Sheet > total Assets
8993165
Annuals > 0 > balance Sheet > payables
481000
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
2333601
Annuals > 0 > balance Sheet > equity
6659564
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-6245737
Annuals > 0 > cash Flow > depreciation
12950
Annuals > 0 > cash Flow > change In Working Capital
251666
Annuals > 0 > cash Flow > cash From Operations
-5486980
Annuals > 0 > cash Flow > capital Expenditures
9160
Annuals > 0 > cash Flow > cash From Investing
-610564
Annuals > 0 > cash Flow > cash From Financing
6757500
Annuals > 0 > cash Flow > net Change In Cash
657602
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-274.68277772891196
Annuals > 0 > ratios > PB
0.005053219700268665
Annuals > 0 > ratios > ROE
-93.78597457731466
Annuals > 0 > ratios > ROA
-69.44982105854835
Annuals > 0 > ratios > FCF
-5496140
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-2.2275947210268074
Annuals > 0 > health Score
33
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
1712595
Annuals > 1 > income Statement > cost Of Revenue
578015
Annuals > 1 > income Statement > gross Profit
1134580
Annuals > 1 > income Statement > operating Expenses
4895000
Annuals > 1 > income Statement > operating Income
-3760081
Annuals > 1 > income Statement > interest Expense
19525
Annuals > 1 > income Statement > pretax Income
-4301517
Annuals > 1 > income Statement > net Income
-4301517
Annuals > 1 > income Statement > eps
-6.298777443100366
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
682913
Annuals > 1 > income Statement > income Tax Expense
1
Annuals > 1 > income Statement > EBITDA
-4270343
Annuals > 1 > income Statement > operating Margin
-219.55459405171683
Annuals > 1 > income Statement > total Other Income Expense Net
-541436
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
3326851
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
36161
Annuals > 1 > balance Sheet > inventories
495667
Annuals > 1 > balance Sheet > total Current Assets
4919444
Annuals > 1 > balance Sheet > property Plant Equipment
259701
Annuals > 1 > balance Sheet > total Assets
5189918
Annuals > 1 > balance Sheet > payables
596147
Annuals > 1 > balance Sheet > short Term Debt
145000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
1362842
Annuals > 1 > balance Sheet > equity
3827076
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-4301517
Annuals > 1 > cash Flow > depreciation
11649
Annuals > 1 > cash Flow > change In Working Capital
-823190
Annuals > 1 > cash Flow > cash From Operations
-4556811
Annuals > 1 > cash Flow > capital Expenditures
11191
Annuals > 1 > cash Flow > cash From Investing
-11191
Annuals > 1 > cash Flow > cash From Financing
6738890
Annuals > 1 > cash Flow > net Change In Cash
2171950
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-6.298777443100366
Annuals > 1 > ratios > PB
0.26409489646926265
Annuals > 1 > ratios > ROE
-112.39695788638637
Annuals > 1 > ratios > ROA
-82.88217655847356
Annuals > 1 > ratios > FCF
-4568002
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-2.667298456435993
Annuals > 1 > health Score
34
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
766277
Annuals > 2 > income Statement > cost Of Revenue
318968
Annuals > 2 > income Statement > gross Profit
447309
Annuals > 2 > income Statement > operating Expenses
2235601
Annuals > 2 > income Statement > operating Income
-1788292
Annuals > 2 > income Statement > interest Expense
2629
Annuals > 2 > income Statement > pretax Income
-1800268
Annuals > 2 > income Statement > net Income
-1800268
Annuals > 2 > income Statement > eps
-0.6612476914871891
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
2722532
Annuals > 2 > income Statement > income Tax Expense
-2
Annuals > 2 > income Statement > EBITDA
-1791127
Annuals > 2 > income Statement > operating Margin
-233.37409318040346
Annuals > 2 > income Statement > total Other Income Expense Net
-11976
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
1154901
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
12854
Annuals > 2 > balance Sheet > inventories
230145
Annuals > 2 > balance Sheet > total Current Assets
1551322
Annuals > 2 > balance Sheet > property Plant Equipment
330088
Annuals > 2 > balance Sheet > total Assets
1892183
Annuals > 2 > balance Sheet > payables
210840
Annuals > 2 > balance Sheet > short Term Debt
110616
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
760873
Annuals > 2 > balance Sheet > equity
1131310
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-1800268
Annuals > 2 > cash Flow > depreciation
6512
Annuals > 2 > cash Flow > change In Working Capital
12433
Annuals > 2 > cash Flow > cash From Operations
-1585876
Annuals > 2 > cash Flow > capital Expenditures
35527
Annuals > 2 > cash Flow > cash From Investing
-32027
Annuals > 2 > cash Flow > cash From Financing
2362259
Annuals > 2 > cash Flow > net Change In Cash
743043
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.6612476914871891
Annuals > 2 > ratios > PB
3.5616651138945117
Annuals > 2 > ratios > ROE
-159.13127259548665
Annuals > 2 > ratios > ROA
-95.14238316272792
Annuals > 2 > ratios > FCF
-1621403
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-2.115948932305159
Annuals > 2 > health Score
25
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
827
Annuals > 3 > income Statement > cost Of Revenue
2845
Annuals > 3 > income Statement > gross Profit
-2018
Annuals > 3 > income Statement > operating Expenses
783044
Annuals > 3 > income Statement > operating Income
-785060
Annuals > 3 > income Statement > interest Expense
0
Annuals > 3 > income Statement > pretax Income
-784739
Annuals > 3 > income Statement > net Income
-784739
Annuals > 3 > income Statement > eps
-0.29031644658786915
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
2703047
Annuals > 3 > income Statement > income Tax Expense
3
Annuals > 3 > income Statement > EBITDA
-782300
Annuals > 3 > income Statement > operating Margin
-94928.65779927449
Annuals > 3 > income Statement > total Other Income Expense Net
321
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
411858
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
1710
Annuals > 3 > balance Sheet > inventories
160817
Annuals > 3 > balance Sheet > total Current Assets
636525
Annuals > 3 > balance Sheet > property Plant Equipment
29725
Annuals > 3 > balance Sheet > total Assets
666250
Annuals > 3 > balance Sheet > payables
98175
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
215622
Annuals > 3 > balance Sheet > equity
450628
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-784739
Annuals > 3 > cash Flow > depreciation
2757
Annuals > 3 > cash Flow > change In Working Capital
-21907
Annuals > 3 > cash Flow > cash From Operations
-660934
Annuals > 3 > cash Flow > capital Expenditures
32482
Annuals > 3 > cash Flow > cash From Investing
-32482
Annuals > 3 > cash Flow > cash From Financing
1090577
Annuals > 3 > cash Flow > net Change In Cash
398507
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.29031644658786915
Annuals > 3 > ratios > PB
8.877632015764666
Annuals > 3 > ratios > ROE
-174.14341763050675
Annuals > 3 > ratios > ROA
-117.78446529080675
Annuals > 3 > ratios > FCF
-693416
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-838.4715840386941
Annuals > 3 > health Score
26
Valuation > metrics > PE
0.0037
Valuation > metrics > PB
0.433799094557487
Valuation > final Score
90
Valuation > verdict
78.3% Undervalued
Profitability > metrics > ROE
-30.555004295899437
Profitability > metrics > ROA
-26.546791749325234
Profitability > metrics > Net Margin
-9.072698532600333
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.7593481303857005
Risk > metrics > Interest Coverage
-11.147536570499797
Risk > final Score
3
Risk > verdict
High
Liquidity > metrics > Current Ratio
2.457187677340696
Liquidity > metrics > Quick Ratio
2.4248859927973747
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
15
Prev Profitabilities > 1
0
Prev Profitabilities > 2
30
Prev Risks > 0
-2028742
Prev Risks > 1
-399
Prev Risks > 2
100
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:45:54.103Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-09-30
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-4.9091
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-09-22
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-8.44
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-8.44
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-14
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-2.9
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-09-30
Earnings History > 3 > report Date
2024-11-14
Earnings History > 3 > date
2024-09-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-94.85
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-06-30
Earnings History > 4 > report Date
2024-06-30
Earnings History > 4 > date
2024-06-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-378.2375
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-03-31
Earnings History > 5 > report Date
2024-03-31
Earnings History > 5 > date
2024-03-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-395.0766
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2023-12-31
Earnings History > 6 > report Date
2023-12-31
Earnings History > 6 > date
2023-12-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-327.4042
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of cutting-edge aesthetic medicines and therapeutic products. The company's lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. It is also involved in the medical scientific research and development activities, as well as operates investment firms. The company was formerly known as Elevai Labs, Inc. and changed its name to PMGC Holdings Inc. in December 2024. PMGC Holdings Inc. was incorporated in 2020 and is based in Newport Beach, California.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/APMGC Holdings (NASDAQ: ELAB) adds $5M prepaid equity with strict terms Stock Titan
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Elevai Labs, Inc. Common Stock
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-4.9091
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.